beta-D-GlcpNAc-(1->3)-beta-D-GalpNAc

Term ID

CHEBI:153935

Synonyms

2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galacto-hexopyranose
2-acetamido-3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-beta-D-galactopyranose
GlcNAc(b1-3)b-GalNAc
N-[(2R,3R,4R,5S,6R)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
WURCS=2.0/2,2,1/[a2112h-1b_1-5_2*NCC/3=O][a2122h-1b_1-5_2*NCC/3=O]/1-2/a3-b1

Definition

A beta-D-GlcpNAc-(1->3)-D-GalpNAc in which the carbon bearing the anomeric hydroxy group has beta configuration.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: beta-D-GlcpNAc-(1->3)-D-GalpNAc

beta-D-GlcpNAc-(1->3)-D-GalpNAc Show first 5 Terms
has_functional_parent: N-acetyl-beta-D-galactosamine N-acetyl-beta-D-glucosamine

N-acetyl-beta-D-galactosamine N-acetyl-beta-D-glucosamine Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->3)-beta-D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->3)-beta-D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->3)-beta-D-GalpNAc

Human Disease Model